{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:36:50Z","timestamp":1778290610214,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-genitourinary-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.clgc.2024.102296","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T16:36:02Z","timestamp":1735403762000},"page":"102296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Does Bladder Outlet Obstruction Releated to Recurrence In Low Risk Ta Low Grade Non Muscle Invasive Bladder Cancer?"],"prefix":"10.1016","volume":"23","author":[{"given":"Serhat","family":"Yentur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3428-547X","authenticated-orcid":false,"given":"Yunus Emre","family":"Dusunus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Ulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail Engin","family":"Kandirali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergen","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2024.102296_bib0001","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102296_bib0002","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","article-title":"European Association of Urology (EAU). EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update","volume":"59","author":"Babjuk","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102296_bib0003","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance Bacillus Calmette-Gu\u00e9rin","volume":"69","author":"Cambier","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102296_bib0004","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/jnci\/djp361","article-title":"A case-control study of smoking and bladder cancer risk: emergent patterns over time","volume":"101","author":"Baris","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clgc.2024.102296_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.juro.2008.03.045","article-title":"The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation","volume":"180","author":"Strope","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2024.102296_bib0006","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin: multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102296_bib0007","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0090-4295(99)00481-1","article-title":"Gender differences in stage distribution of bladder cancer","volume":"55","author":"Mungan","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2024.102296_bib0008","article-title":"Urodynamic tests, uroflow, single and multichannel cystometry, urethral pressure profilometry, videourodynamics. Basic Urogynecology, \u00d6nay Yal\u00e7\u0131n; chapter 21","author":"Erol","year":"2009","journal-title":"Nobel Medical Bookstore"},{"issue":"4","key":"10.1016\/j.clgc.2024.102296_bib0009","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4103\/0970-1591.29114","article-title":"Does estimation of prostate volume by abdominal ultrasonography vary with bladder volume: a prospective study with transrectal ultrasonography as a reference","volume":"22","author":"Bapat","year":"2006","journal-title":"Indian Journal of Urology"},{"key":"10.1016\/j.clgc.2024.102296_bib0010","doi-asserted-by":"crossref","first-page":"e3493","DOI":"10.1097\/MD.0000000000003493","article-title":"Benign prostatic hyperplasia and the risk of prostate cancer and bladder cancer: a meta-analysis of observational studies","volume":"95","author":"Dai","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clgc.2024.102296_bib0011","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1590\/s1677-5538.ibju.2018.0068","article-title":"Moderate or severe LUTS is associated with increased recurrence of non-muscle-invasive urothelial carcinoma of the bladder","volume":"45","author":"Lunney","year":"2019","journal-title":"Int. Braz. J. Urol."},{"key":"10.1016\/j.clgc.2024.102296_bib0012","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.urology.2015.02.024","article-title":"Lower urinary tract symptoms and risk of bladder cancer in men: rresults from the health professionals follow-up study","volume":"85","author":"Zhou","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2024.102296_bib0013","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1464-410X.2008.08261.x","article-title":"Bladder outlet obstruction accelerates bladder carcinogenesis","volume":"103","author":"Matsumoto","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2024.102296_bib0014","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clgc.2024.102296_bib0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2407-13-7","article-title":"Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan","volume":"13","author":"Tseng","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clgc.2024.102296_bib0016","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.juro.2016.08.006","article-title":"Suppressed recurrent bladder cancer after androgen suppression with androgen deprivation therapy or 5\u03b1-reductase inhibitor","volume":"197","author":"Shiota","year":"2017","journal-title":"J. Urol."},{"key":"10.1016\/j.clgc.2024.102296_bib0017","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.18632\/oncotarget.2851","article-title":"Androgen deprivation therapy prevents bladder cancer recurrence","volume":"5","author":"Izumi","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.clgc.2024.102296_bib0018","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/cancers9020020","article-title":"Androgen receptor signaling in bladder cancer","volume":"9","author":"Li","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clgc.2024.102296_bib0019","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3892\/mco.2017.1389","article-title":"Expression and clinical significance of androgen receptor in bladder cancer: a meta-analysis","volume":"7","author":"Chen","year":"2017","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.clgc.2024.102296_bib0020","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1186\/s12885-020-07373-4","article-title":"5\u03b1-reductase inhibitors impact prognosis of urothelial carcinoma","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.clgc.2024.102296_bib0021","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00428-015-1820-x","article-title":"Chronic inflammation in urothelial bladder cancer","volume":"467","author":"Nesi","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1016\/j.clgc.2024.102296_bib0022","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/ijc.23572","article-title":"Does increased urination frequency protect against bladder cancer?","volume":"123","author":"Silverman","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clgc.2024.102296_bib0023","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM199905063401803","article-title":"Fluid intake and the risk of bladder cancer in men","volume":"340","author":"Michaud","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clgc.2024.102296_bib0024","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.juro.2008.11.099","article-title":"Long-term outcome of simultaneous transurethral resection of bladder tumor and prostate in patients with nonmuscle invasive bladder tumor and bladder outlet obstruction","volume":"181","author":"Ham","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2024.102296_bib0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/end.2010.0314","article-title":"Does simultaneous transurethral resection of bladder tumor and prostate affect the recurrence of bladder tumor? A meta-analysis","volume":"25","author":"Luo","year":"2011","journal-title":"J Endourol"},{"key":"10.1016\/j.clgc.2024.102296_bib0026","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3892\/etm.2012.660","article-title":"Simultaneous transurethral resection of bladder cancer and prostate may reduce recurrence rates: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2012","journal-title":"Exp Ther Med"},{"issue":"2","key":"10.1016\/j.clgc.2024.102296_bib0027","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000144048","article-title":"Simultaneous transurethral resection of bladder tumor and prostate: is it safe?","volume":"81","author":"Hryssanthos","year":"2008","journal-title":"Urol Int"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324002660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324002660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:36:27Z","timestamp":1741696587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767324002660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1558767324002660"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102296","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Bladder Outlet Obstruction Releated to Recurrence In Low Risk Ta Low Grade Non Muscle Invasive Bladder Cancer?","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102296"}}